Correction to: Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons

Amy Wallis; Michelle Ball; Henry Butt; Donald P Lewis; Sandra McKechnie; Phillip Paull; Amber Jaa-Kwee; Dorothy Bruck

doi:10.1186/s12967-018-1413-y

Correction to: Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons

J Transl Med. 2018 Feb 23;16(1):39. doi: 10.1186/s12967-018-1413-y.

Authors

Amy Wallis¹, Michelle Ball², Henry Butt³, Donald P Lewis⁴, Sandra McKechnie⁵, Phillip Paull³, Amber Jaa-Kwee⁵, Dorothy Bruck²

Affiliations

¹ Psychology Department, College of Health and Biomedicine, Victoria University, Melbourne, Australia. Amy.Wallis@vu.edu.au.
² Psychology Department, College of Health and Biomedicine, Victoria University, Melbourne, Australia.
³ Bioscreen (Aust) Pty Ltd., Melbourne, Australia.
⁴ CFS Discovery Clinic, Donvale, Melbourne, Australia.
⁵ College of Engineering and Science, Victoria University, Melbourne, Australia.

Abstract

The original version of this article [1], published on 6 February 2018, contains a mistake in the 'Conclusions' section. The corrected version of the affected sentence is given below and the corrected part is marked in bold.

Publication types

Published Erratum